marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-06-2024
REGENXBIO Balance Sheet 2011-2024 | RGNX
Annual Balance Sheet REGENXBIO
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
54.8 M | -2.15 M | -259 M | - | -58.2 M | -69.7 M | -46.7 M | -24.8 M | -54.1 M | 1.28 M | -1.12 M | - | - |
Long Term Debt |
82.2 M | 88.8 M | 84.9 M | - | - | - | - | - | - | - | - | - | - |
Long Term Debt Current |
7.07 M | 6 M | 1.75 M | 2.5 M | 2.42 M | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | 14 M | 12.8 M | 1.21 M | 1.33 M | 233 K | - | - | - | - |
Total Current Liabilities |
130 M | 130 M | 130 M | 81.4 M | 33.7 M | 22.2 M | 14.4 M | 9.67 M | 4.34 M | - | - | - | - |
Total Liabilities |
262 M | 317 M | 350 M | 330 M | 47.7 M | 35 M | 15.6 M | 11 M | 4.57 M | 9.19 M | 4.65 M | - | - |
Deferred Revenue |
148 K | 1.83 M | 3.33 M | 449 K | - | 600 K | - | - | 127 K | 153 K | - | - | - |
Retained Earnings |
-705 M | -442 M | -161 M | -289 M | -178 M | -83 M | -188 M | -115 M | -51.6 M | -28.8 M | -24.8 M | - | - |
Total Assets |
574 M | 833 M | 1.11 B | 708 M | 498 M | 544 M | 199 M | 173 M | 221 M | 3.49 M | 2.51 M | - | - |
Cash and Cash Equivalents |
34.5 M | 97 M | 345 M | 338 M | 69.5 M | 75.6 M | 46.7 M | 24.8 M | 54.1 M | 1.12 M | 1.12 M | - | - |
Book Value |
312 M | 516 M | 764 M | 378 M | 450 M | 509 M | 183 M | 162 M | 217 M | -5.7 M | -2.14 M | - | - |
Total Shareholders Equity |
312 M | 516 M | 764 M | 378 M | 450 M | 509 M | 183 M | 162 M | 217 M | -18.3 M | -13.9 M | - | - |
All numbers in USD currency
Quarterly Balance Sheet REGENXBIO
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
76.3 M | 78.2 M | 80.2 M | 82.2 M | 84.1 M | 85.3 M | 87 M | 88.8 M | 84.7 M | - | 85.6 M | 84.9 M | 83.9 M | 82.4 M | 75.1 M | 70.2 M | 70.2 M | 70.2 M | 70.2 M | 8.87 M | 8.87 M | 8.87 M | 8.87 M | 5.85 M | 5.85 M | 5.85 M | 5.85 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
218 M | 221 M | 239 M | 262 M | 271 M | 277 M | 283 M | 317 M | 320 M | - | 336 M | 350 M | 339 M | 329 M | 325 M | 330 M | 330 M | 330 M | 330 M | 47.7 M | 47.7 M | 47.7 M | 47.7 M | 35 M | 35 M | 35 M | 35 M | 15.6 M | 15.6 M | 15.6 M | 15.6 M | 11 M | 11 M | 11 M | 11 M | 4.57 M | 4.57 M | 4.57 M | 4.57 M | 9.19 M | 9.19 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
144 K | 21 K | 13 K | 148 K | 442 K | 448 K | 1.31 M | 1.83 M | 5.9 M | - | 3.33 M | 3.33 M | 395 K | 395 K | 395 K | 449 K | 449 K | 449 K | 449 K | - | - | - | 600 K | 600 K | 600 K | 600 K | 600 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-881 M | -821 M | -768 M | -705 M | -642 M | -580 M | -508 M | -442 M | -382 M | - | -238 M | -161 M | -455 M | -397 M | -339 M | -289 M | -289 M | -289 M | -289 M | -178 M | -178 M | -178 M | -178 M | -83 M | -83 M | -83 M | -83 M | -188 M | -188 M | -188 M | -188 M | -115 M | -115 M | -115 M | -115 M | -51.6 M | -51.6 M | -51.6 M | -51.6 M | -28.8 M | -28.8 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Assets |
519 M | 569 M | 629 M | 574 M | 634 M | 682 M | 748 M | 833 M | 884 M | - | 1.03 B | 1.11 B | 800 M | 836 M | 879 M | 708 M | 708 M | 708 M | 708 M | 498 M | 498 M | 498 M | 498 M | 544 M | 544 M | 544 M | 544 M | 199 M | 199 M | 199 M | 199 M | 173 M | 173 M | 173 M | 173 M | 221 M | 221 M | 221 M | 221 M | 3.49 M | 3.49 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
56.6 M | 57.8 M | 113 M | 34.5 M | 53 M | 68.6 M | 70.1 M | 97 M | 119 M | 121 M | 192 M | 345 M | 228 M | 257 M | 291 M | 338 M | 338 M | 338 M | 338 M | 69.5 M | 69.5 M | 69.5 M | 69.5 M | 75.6 M | 75.6 M | 75.6 M | 75.6 M | 46.7 M | 46.7 M | 46.7 M | 46.7 M | 24.8 M | 24.8 M | 24.8 M | 24.8 M | 54.1 M | 54.1 M | 54.1 M | 54.1 M | 1.12 M | 1.12 M | - | - | 1.12 M | - | - | - | 2.17 M | - | - | - | - | - | - | - |
Book Value |
301 M | 348 M | 391 M | 312 M | 363 M | 406 M | 465 M | 516 M | 564 M | - | 690 M | 764 M | 461 M | 507 M | 555 M | 378 M | 378 M | 378 M | 378 M | 450 M | 450 M | 450 M | 450 M | 509 M | 509 M | 509 M | 509 M | 183 M | 183 M | 183 M | 183 M | 162 M | 162 M | 162 M | 162 M | 217 M | 217 M | 217 M | 217 M | -5.7 M | -5.7 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
301 M | 348 M | 391 M | 312 M | 363 M | 406 M | 465 M | 516 M | 564 M | 631 M | 690 M | 764 M | 461 M | 507 M | 555 M | 378 M | 378 M | 378 M | 378 M | 450 M | 450 M | 450 M | 450 M | 509 M | 509 M | 509 M | 509 M | 183 M | 183 M | 183 M | 183 M | 162 M | 162 M | 162 M | 162 M | 217 M | 217 M | 217 M | 217 M | -18.3 M | -18.3 M | - | - | -13.9 M | - | - | - | -8.11 M | - | - | - | - | - | - | - |
All numbers in USD currency